• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form EFFECT filed by Sigilon Therapeutics Inc.

    8/16/23 12:15:09 AM ET
    $SGTX
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $SGTX alert in real time by email
    Notice of Effectiveness
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    Notice of Effectiveness
    Effectiveness Date: August 15, 2023
    Accession Number: 0001193125-23-210776
    Submission Type: POS AM
    CIK: 0001821323
    Company Name: Sigilon Therapeutics, Inc.
    File Number: 333-264296
    Get the next $SGTX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SGTX

    DatePrice TargetRatingAnalyst
    12/23/2021$12.00 → $7.00Buy
    Canaccord Genuity
    12/1/2021$16.00 → $7.00Overweight
    Barclays
    11/30/2021$9.00 → $4.50Equal-Weight
    Morgan Stanley
    11/30/2021$15.00 → $4.00Buy → Hold
    Jefferies
    10/29/2021$14.00Buy
    BTIG
    8/2/2021$15.00Buy
    Jefferies
    7/19/2021$62.00 → $43.00Buy
    Canaccord Genuity
    7/16/2021$45.00 → $9.00Equal-Weight
    Morgan Stanley
    More analyst ratings